MS
Manickaraj Saranya
About Manickaraj Saranya
Data last updated:
Manickaraj Saranya has 1 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Moonshot Advisory Private Limited and Saranya Children Clinic Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Moonshot Advisory Private Limited U70200TS2025PTC201955 | Director | 05 Aug 2025 | 2025 | – | Active |
| Saranya Children Clinic Llp ACN-5160 | Designated Partner | 10 Apr 2025 | 2025 | – | Active |
| Prasaro Meditech Private Limited U62099KA2024PTC195585 | Director | 03 Dec 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manickaraj Saranya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manickaraj Saranya
Manickaraj Saranya has 1 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Moonshot Advisory Private Limited and Saranya Children Clinic Llp. Engaged in General Business, Technology. Contributes to corporate operations.
Manickaraj Saranya is associated with 3 companies as Director and Designated Partner, including Moonshot Advisory Private Limited, Saranya Children Clinic Llp, Prasaro Meditech Private Limited.
Manickaraj Saranya has expertise in General Business, Technology.
Manickaraj Saranya has 1 years in corporate governance.
Manickaraj Saranya currently holds positions at 3 companies: Moonshot Advisory Private Limited, Saranya Children Clinic Llp, Prasaro Meditech Private Limited.